Autofocusing Smart Glasses With Eye Tracking Tech Could Make Bifocals Obsolete
Exciting news for those enough who are 40+ and spend too much time in front of a computer screen: a Finnish startup called IXI is promising to end the era of clunky bifocals and the โhead-tiltโ struggle of progressive lenses, replacing them with a pair of glasses that focus as naturally as the human eye using a combination of infrared eye tracking and liquid crystal-transparent indium tin oxide glasses

An eyewear breakthrough by Finnish company IXI is promising to end the era of clunky bifocals and the 'head-tilt' struggle of progressive lenses, replacing them with a pair of glasses that focus as naturally as the human eye.
Went to #opticians last week for eye test and checkup, was slightly cursing myself for driving short distance but it was cold and pissing down with rain. Had to fight cursed #UI of parking machine to get my pay and display ticket (took several tries, but I refuse to download yet another app)
Thankfully my distant #eyesight is no worse than 2 years ago (although my #presbyopia has increased slightly to +1,50) - managed to unearth a #vuln in an #OCT scanner as I am very nearsighted - the level of this overflowed the software, optician had to use a different one!
Was shown all the pictures of the inside of my eye/optic nerve etc, all was good there (considering my age and near sight)
Got some #ramen from one of the Asian shops but didn't hang around long in town due to #weather (brr!)
Listening to Mary Roach on Replacing Parts of Our Bodies on the Mindscape #podcast was very interesting.
A thing I learned (and read up): you may be able to wear one contact lens for #myopia and one for #presbyopia (the thing when you get older and need reading glasses) in different eyes and your brain can make use of it. I will surely test this!
Be warned: There is quite graphic talk about surgery and body parts.
Eye Drops Offer Non-Surgical Alternative for Age-Related Vision Loss
As people age, many experience presbyopia, a condition that makes it difficult to read up close. Traditionally, reading glasses have been the go-to solution, but new research presents a potentially better option: eye drops. In a study conducted on 766 patients, researchers tested a combination of pi... [More info]
FDA approves Vizz eye drops, offering a new non-surgical option for presbyopia, the age related loss of near vision. Developed by Lenz Therapeutics, Vizz works within 30 minutes, lasts up to 10 hours, and showed no serious side effects in trials spanning 30,000+ treatment days. U.S. rollout begins late 2025. ๐ค
#health #vision #eyecare #medicine #fda #presbyopia #science
https://medicalxpress.com/news/2025-08-fda-vizz-eye-vision-adults.html
What do Vuity (a drop for presbyopia aka near vision loss) and Ortho-K night lenses for myopia have in common?
Turns outโthey can both help with glare and halos at night.
Sometimes I adjust the OrthoK lens design.
Other times, I use Vuity to shrink the pupil by 1โ2mm.
Different tools, same goal: clearer night vision. ๐โจ
#myopiatreatment #myopiamanagement#myopiamanagement #OrthoK #Vuity #NightVision #MyopiaControl #Presbyopia #OptometristLife
In which it is suggested that #Novartis pulled the plug on a trial of eyedrops that could cure age-related far sightedness (#presbyopia) because other pharmaceutical firms sought approval for eyedrops that can only mitigate it, by distorting the way your eye focuses, for a day at a time.
https://pharmaphorum.com/news/novartis-drops-presbyopia-drug-acquired-with-encore-vision
What's the point in treating an ailment that hinders millions around the globe if you can create a revenue stream of dependency by alleviating it only for a day at a time instead? ๐
Novartis has abandoned development of its drug to treat presbyopia, a common age-related loss of near distance vision, after it failed a phase 2b trial. The eyedrop formulation of UNR844 (lipoic acid/choline ester chloride) was acquired as part of the group's buyout of privately-held ophthalmology biotech Encore Vision for $375 million upfront in 2017, and was designed to work by restoring the elasticity of the eye's lens that declines with age.